vs

Side-by-side financial comparison of eXp World Holdings, Inc. (EXPI) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.

eXp World Holdings, Inc. is the larger business by last-quarter revenue ($1.2B vs $1.1B, roughly 1.1× PERRIGO Co plc). eXp World Holdings, Inc. runs the higher net margin — -1.1% vs -127.8%, a 126.7% gap on every dollar of revenue. On growth, eXp World Holdings, Inc. posted the faster year-over-year revenue change (8.5% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $11.9M). Over the past eight quarters, eXp World Holdings, Inc.'s revenue compounded faster (12.4% CAGR vs 1.3%).

eXp World Holdings, Inc. is a global cloud-based real estate services provider. It operates the eXp Realty brokerage network, leverages immersive virtual 3D campus environments to support agent collaboration and operations, serves residential and commercial real estate markets across over 20 countries, and offers complementary services including mortgage, title insurance and professional development resources for real estate practitioners.

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...

EXPI vs PRGO — Head-to-Head

Bigger by revenue
EXPI
EXPI
1.1× larger
EXPI
$1.2B
$1.1B
PRGO
Growing faster (revenue YoY)
EXPI
EXPI
+11.0% gap
EXPI
8.5%
-2.5%
PRGO
Higher net margin
EXPI
EXPI
126.7% more per $
EXPI
-1.1%
-127.8%
PRGO
More free cash flow
PRGO
PRGO
$136.7M more FCF
PRGO
$148.6M
$11.9M
EXPI
Faster 2-yr revenue CAGR
EXPI
EXPI
Annualised
EXPI
12.4%
1.3%
PRGO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EXPI
EXPI
PRGO
PRGO
Revenue
$1.2B
$1.1B
Net Profit
$-12.9M
$-1.4B
Gross Margin
32.6%
Operating Margin
-1.1%
-116.0%
Net Margin
-1.1%
-127.8%
Revenue YoY
8.5%
-2.5%
Net Profit YoY
-35.7%
-3093.9%
EPS (diluted)
$-0.08
$-10.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXPI
EXPI
PRGO
PRGO
Q4 25
$1.2B
$1.1B
Q3 25
$1.3B
$1.0B
Q2 25
$1.3B
$1.1B
Q1 25
$954.9M
$1.0B
Q4 24
$1.1B
$1.1B
Q3 24
$1.2B
$1.1B
Q2 24
$1.3B
$1.1B
Q1 24
$943.1M
$1.1B
Net Profit
EXPI
EXPI
PRGO
PRGO
Q4 25
$-12.9M
$-1.4B
Q3 25
$3.5M
$7.5M
Q2 25
$-2.3M
$-8.4M
Q1 25
$-11.0M
$-6.4M
Q4 24
$-9.5M
$-44.4M
Q3 24
$-8.5M
$-21.0M
Q2 24
$12.4M
$-108.4M
Q1 24
$-15.6M
$2.0M
Gross Margin
EXPI
EXPI
PRGO
PRGO
Q4 25
32.6%
Q3 25
36.1%
Q2 25
34.4%
Q1 25
37.6%
Q4 24
33.9%
Q3 24
99.9%
37.2%
Q2 24
99.9%
37.0%
Q1 24
33.1%
Operating Margin
EXPI
EXPI
PRGO
PRGO
Q4 25
-1.1%
-116.0%
Q3 25
0.3%
7.0%
Q2 25
-0.2%
4.3%
Q1 25
-1.1%
4.5%
Q4 24
-1.0%
10.0%
Q3 24
-0.7%
7.4%
Q2 24
1.4%
-2.5%
Q1 24
-1.9%
-5.1%
Net Margin
EXPI
EXPI
PRGO
PRGO
Q4 25
-1.1%
-127.8%
Q3 25
0.3%
0.7%
Q2 25
-0.2%
-0.8%
Q1 25
-1.2%
-0.6%
Q4 24
-0.9%
-3.9%
Q3 24
-0.7%
-1.9%
Q2 24
1.0%
-10.2%
Q1 24
-1.7%
0.2%
EPS (diluted)
EXPI
EXPI
PRGO
PRGO
Q4 25
$-0.08
$-10.23
Q3 25
$0.02
$0.05
Q2 25
$-0.01
$-0.06
Q1 25
$-0.07
$-0.05
Q4 24
$-0.06
$-0.32
Q3 24
$-0.06
$-0.15
Q2 24
$0.08
$-0.79
Q1 24
$-0.10
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXPI
EXPI
PRGO
PRGO
Cash + ST InvestmentsLiquidity on hand
$124.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$242.8M
$2.9B
Total Assets
$442.5M
$8.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXPI
EXPI
PRGO
PRGO
Q4 25
$124.2M
Q3 25
$112.8M
$432.1M
Q2 25
$94.6M
$454.2M
Q1 25
$115.7M
$409.9M
Q4 24
$113.6M
$558.8M
Q3 24
$130.4M
$1.5B
Q2 24
$108.4M
$542.8M
Q1 24
$109.2M
$658.5M
Stockholders' Equity
EXPI
EXPI
PRGO
PRGO
Q4 25
$242.8M
$2.9B
Q3 25
$235.3M
$4.4B
Q2 25
$218.4M
$4.5B
Q1 25
$212.0M
$4.4B
Q4 24
$204.9M
$4.3B
Q3 24
$211.1M
$4.6B
Q2 24
$220.3M
$4.5B
Q1 24
$222.4M
$4.7B
Total Assets
EXPI
EXPI
PRGO
PRGO
Q4 25
$442.5M
$8.5B
Q3 25
$458.7M
$10.1B
Q2 25
$481.2M
$10.1B
Q1 25
$435.8M
$9.8B
Q4 24
$390.7M
$9.6B
Q3 24
$432.6M
$11.2B
Q2 24
$457.4M
$10.4B
Q1 24
$426.7M
$10.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXPI
EXPI
PRGO
PRGO
Operating Cash FlowLast quarter
$13.8M
$175.4M
Free Cash FlowOCF − Capex
$11.9M
$148.6M
FCF MarginFCF / Revenue
1.0%
13.4%
Capex IntensityCapex / Revenue
0.2%
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$109.0M
$145.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXPI
EXPI
PRGO
PRGO
Q4 25
$13.8M
$175.4M
Q3 25
$28.9M
$51.7M
Q2 25
$36.1M
$75.9M
Q1 25
$39.8M
$-64.5M
Q4 24
$13.7M
$312.6M
Q3 24
$46.0M
$42.2M
Q2 24
$71.1M
$9.5M
Q1 24
$60.7M
$-1.4M
Free Cash Flow
EXPI
EXPI
PRGO
PRGO
Q4 25
$11.9M
$148.6M
Q3 25
$26.6M
$29.8M
Q2 25
$33.3M
$56.7M
Q1 25
$37.3M
$-90.0M
Q4 24
$11.6M
$274.9M
Q3 24
$44.4M
$15.1M
Q2 24
$69.7M
$-18.9M
Q1 24
$59.3M
$-26.5M
FCF Margin
EXPI
EXPI
PRGO
PRGO
Q4 25
1.0%
13.4%
Q3 25
2.0%
2.9%
Q2 25
2.5%
5.4%
Q1 25
3.9%
-8.6%
Q4 24
1.1%
24.2%
Q3 24
3.6%
1.4%
Q2 24
5.4%
-1.8%
Q1 24
6.3%
-2.4%
Capex Intensity
EXPI
EXPI
PRGO
PRGO
Q4 25
0.2%
2.4%
Q3 25
0.2%
2.1%
Q2 25
0.2%
1.8%
Q1 25
0.3%
2.4%
Q4 24
0.2%
3.3%
Q3 24
0.1%
2.5%
Q2 24
0.1%
2.7%
Q1 24
0.1%
2.3%
Cash Conversion
EXPI
EXPI
PRGO
PRGO
Q4 25
Q3 25
8.26×
6.89×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
5.75×
Q1 24
-0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXPI
EXPI

North American Realty$1.1B96%
International Realty$42.2M4%

PRGO
PRGO

Consumer Self Care Americas$697.0M63%
Digestive Health$123.9M11%
Nutrition$108.3M10%
Healthy Lifestyle$94.8M9%
Pain And Sleep Aids$87.1M8%

Related Comparisons